Overview

Arthur Ritchey is a Pediatrics provider in Pittsburgh, Pennsylvania. His top areas of expertise are Childhood Pancreatitis, RASopathies, Infantile Neutropenia, and Mast Cell Activation Syndrome (MCAS).

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Licenses
Specialist in PA
Languages Spoken
English
Gender
Male

Insurance

MediFind strives to display the most accurate insurance information for every doctor. Please contact your provider to confirm if they accept your insurance.


Dr. Arthur K. Ritchey accepts the following insurance:

  •  Humana

Locations

3414 5th Ave, Chob Building, 1st Floor, Pittsburgh, PA 15213
412-692-5055

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


17 Clinical Trials

Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
View 16 Less Clinical Trials
Similar Doctors
Alejandro M. Hoberman
Expertise in
3
conditions
Expertise in
3
conditions
3414 5th Ave, Chob Building, 1st Floor, 
Pittsburgh, PA 

Alejandro Hoberman is a Pediatrics provider in Pittsburgh, Pennsylvania. Dr. Hoberman is highly rated in 3 conditions, according to our data. His top areas of expertise are Urinary Tract Infection in Children, Otitis Media with Effusion, Diarrhea, High Blood Pressure in Infants, and Myringotomy.

Expertise in
6
conditions
Pediatrics | Medical Genetics
Expertise in
6
conditions
Pediatrics | Medical Genetics

University Of Pittsburgh Physicians

4401 Penn Ave, 
Pittsburgh, PA 
 1.9 mi

Uta Lichter-Konecki is a Pediatrics specialist and a Medical Genetics provider in Pittsburgh, Pennsylvania. Dr. Lichter-Konecki is highly rated in 6 conditions, according to our data. Her top areas of expertise are Urea Cycle Disorders (UCD), Phenylketonuria (PKU), Maple Syrup Urine Disease, and Inborn Amino Acid Metabolism Disorder.

Expertise in
11
conditions
Pediatric Gastroenterology | Pediatrics
Expertise in
11
conditions
Pediatric Gastroenterology | Pediatrics
3705 5th Ave, Pediatric Gastroenterology, 
Pittsburgh, PA 
 0.1 mi
Accepting New Patients

Benjamin Shneider is a Pediatric Gastroenterologist and a Pediatrics provider in Pittsburgh, Pennsylvania. Dr. Shneider is highly rated in 11 conditions, according to our data. His top areas of expertise are Biliary Atresia, Alagille Syndrome, Cholestasis, Liver Transplant, and Endoscopy. Dr. Shneider is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile